{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:22:08Z","timestamp":1791138128698,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.ejpb.2006.11.021","type":"journal-article","created":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T14:24:32Z","timestamp":1165069472000},"page":"348-356","source":"Crossref","is-referenced-by-count":77,"title":["Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles"],"prefix":"10.1016","volume":"66","author":[{"given":"Ann Marie","family":"Kaukonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarno","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaani","family":"Tuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Heikkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Limnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouni","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa-Pekka","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2006.11.021_bib1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1359-6446(03)02874-5","article-title":"Controlled release technologies for drug delivery","volume":"8","author":"Brayden","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2006.11.021_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00487-5","article-title":"Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract","volume":"25","author":"H\u00f6rter","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2006.11.021_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Method"},{"key":"10.1016\/j.ejpb.2006.11.021_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-5173(00)00344-6","article-title":"Biopharmaceutics and pharmacokinetics in drug research","volume":"201","author":"Panchagnula","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.11.021_bib5","article-title":"Advancing new drug delivery concepts to gain a lead","volume":"3","author":"Horspool","year":"2002","journal-title":"Drug Deliv. Technol."},{"key":"10.1016\/j.ejpb.2006.11.021_bib6","article-title":"Chemical stability studies of thermally-carbonized porous silicon","volume":"638","author":"Salonen","year":"2001","journal-title":"Mat. Res. Soc. (MRS) Symp. Proc."},{"key":"10.1016\/j.ejpb.2006.11.021_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","article-title":"Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs","volume":"108","author":"Salonen","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2006.11.021_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.addr.2003.10.007","article-title":"Impact of solid state properties on developability assessment of drug candidates","volume":"56","author":"Huang","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2006.11.021_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(01)00098-9","article-title":"Amorphous pharmaceutical solids: preparation, characterization and stabilization","volume":"48","author":"Yu","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2006.11.021_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1023\/A:1022211127890","article-title":"Microfabricated Porous Silicon Particles Enhance Paracellular Delivery of Insulin Across Intestinal Caco-2 Cell Monolayers","volume":"20","author":"Foraker","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib11","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1021\/cm0401490","article-title":"Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices","volume":"16","author":"Andersson","year":"2004","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejpb.2006.11.021_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10717540490265252","article-title":"Drug delivery devices based on mesoporous silicate","volume":"11","author":"Cavallaro","year":"2004","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ejpb.2006.11.021_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2004.03.005","article-title":"Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery","volume":"97","author":"Doadrio","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2006.11.021_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/cm021217q","article-title":"MCM-41 organic modification as drug delivery rate regulator","volume":"15","author":"Munoz","year":"2003","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejpb.2006.11.021_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ssi.2004.04.036","article-title":"Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin","volume":"172","author":"Vallet-Regi","year":"2004","journal-title":"Solid State Ionics"},{"key":"10.1016\/j.ejpb.2006.11.021_bib16","first-page":"21","article-title":"Nanotechnology applications for drug delivery","volume":"17","author":"Aston","year":"2005","journal-title":"Pharm. Tech."},{"key":"10.1016\/j.ejpb.2006.11.021_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejpb.2003.12.007","article-title":"Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property","volume":"57","author":"Charnay","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2006.11.021_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1039\/B307046H","article-title":"Synthesis and characterization of ibuprofen-anchored MCM-41 silica and silica gel","volume":"27","author":"Tourne-Peteilh","year":"2003","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejpb.2006.11.021_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.2042-7158.1989.tb06396.x","article-title":"The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide\u2013PVP solid dispersions","volume":"41","author":"Doherty","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2006.11.021_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(90)90185-7","article-title":"Physicochemical characterization of furosemide modifications","volume":"60","author":"Matsuda","year":"1990","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.11.021_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1568026013395100","article-title":"Physicochemical profiling (solubility, permeability and charge state)","volume":"1","author":"Avdeef","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejpb.2006.11.021_bib22","series-title":"Absorption and Drug Development: Solubility, Permeability, and Charge State","author":"Avdeef","year":"2003"},{"key":"10.1016\/j.ejpb.2006.11.021_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1007552927404","article-title":"Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans","volume":"17","author":"Chiou","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/js980111k","article-title":"Link between drug absorption solubility and permeability measurements in Caco-2 cells","volume":"87","author":"Pade","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.11.021_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.11.021_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.11.021_bib28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0091270003254575","article-title":"Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers","volume":"43","author":"Klausner","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2006.11.021_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0928-0987(03)00121-0","article-title":"Evaluation of microcrystalline chitosans for gastro-retentive drug delivery","volume":"19","author":"S\u00e4kkinen","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.11.021_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1018868123367","article-title":"Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat jejunum","volume":"16","author":"Flanagan","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000056161","article-title":"Comparison of furosemide and vinblastine secretion from cell lines overexpressing multidrug resistance protein (P-glycoprotein) and multidrug resistance-associated proteins (MRP1 and MRP2)","volume":"64","author":"Flanagan","year":"2002","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejpb.2006.11.021_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10973-005-0666-x","article-title":"Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles","volume":"80","author":"Lehto","year":"2005","journal-title":"J. Therm. Anal. Cal."},{"key":"10.1016\/j.ejpb.2006.11.021_bib33","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/pssa.200461204","article-title":"Determination of drug load in porous silicon microparticles by calorimetry","volume":"202","author":"Salonen","year":"2005","journal-title":"Phys. Stat. Solid (A) Appl. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jps.2600820214","article-title":"pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances","volume":"82","author":"Avdeef","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.11.021_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/cr60274a001","article-title":"Partition coefficients and their uses","volume":"71","author":"Leo","year":"1971","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2006.11.021_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(88)90225-6","article-title":"Frusemide crystal forms; solid state and physicochemical analyses","volume":"47","author":"Doherty","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.11.021_bib37","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jps.10099","article-title":"Contributions of saturable active secretion, passive transcellular, and paracellular diffusion to the overall transport of furosemide across adenocarcinoma (Caco-2) cells","volume":"91","author":"Flanagan","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.11.021_bib38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1012111008617","article-title":"Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model","volume":"14","author":"Pade","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1023\/A:1011022931368","article-title":"Profound effect of plasma protein binding on the polarized transport of furosemide and verapamil in the Caco-2 model","volume":"18","author":"Chung","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2006.11.021_bib40","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/jps.1127","article-title":"Effect of common excipients on Caco-2 transport of low-permeability drugs","volume":"90","author":"Rege","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.11.021_bib41","doi-asserted-by":"crossref","first-page":"G608","DOI":"10.1152\/ajpgi.1985.248.6.G608","article-title":"Mechanisms maintaining a low-pH microclimate in the intestine","volume":"248","author":"Shiau","year":"1985","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641106003432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641106003432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T17:56:10Z","timestamp":1555955770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641106003432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0939641106003432"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2006.11.021","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}